All
Patients with Mesothelioma See No Survival Benefit With Defactinib Maintenance Therapy
June 18th 2019Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.
When Beating Cancer Means Battling the System
June 17th 2019When my oncologist wanted to start me on a standard treatment, I asked her why. She said some of her other patients had gotten it. She was basing my life on someone else’s results? This survivor decided to seek other opinions and became her own advocate.
Redefining Success After Breast Cancer
June 13th 2019Breast cancer was one of the best things that ever happened to me – and I never want it again. Now I am cancer-free and living a more fulfilling life than before the illness. Here are 10 insights and experiences from my cancer journey that continue to sustain me professionally and personally.
FDA Approves Keytruda Regimens to Treat Head and Neck Squamous Cell Carcinoma
June 11th 2019The Food and Drug Administration approved Keytruda monotherapy and in combination with chemotherapy for the front-line treatments of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma.
FDA Grants Polivy Accelerated Approval for DLBCL
June 10th 2019The FDA has granted an accelerated approval to Polivy for use in combination with bendamustine and Rituxan for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies.
Older Patients With Blood Cancer Should Discuss Daily Function With Their Health Care Team
June 10th 2019Researchers determined that having difficulty performing at least one instrumental activity of daily living puts older patients at risk of death, unplanned hospitalization and emergency department visits.